.svg)
Background
The Bacille Calmette-Guérin (BCG) vaccine was first trialed in the early 1900s as a vaccine against Tuberculosis. Today, the BCG vaccine is given to healthy babies in countries where tuberculosis and leprosy are prevalent.
The first recorded case of the COVID-19 outbreak originated from Wuhan, China in early December. By February, the World Health Organization declared COVID-19 a Public Health Emergency of International Concern, categorised as a pandemic the following month.
As most Australian's were learning about COVID-19, MCRI's Infectious Diseases Research Group Leader, Professor Nigel Curtis and his team had clues that the BCG vaccine may be able to reduce the severity of coronavirus symptoms. They reached out to WeGuide in hopes of identifying a seamless method to gather participant data.
Challenge
The challenge for this project was vast: how can we gather daily symptom data from thousands of participants around the world?
Professor Nigel Curtis and his team were met with three different challenges:
Remote Collaboration
How could we scope, build and execute on a platform while fully remote during a global pandemic?
Rapid Turnaround Time
How can we build an app within 3 weeks, given app development often takes 3-6 months?
Complex Data Capture
How can we securely capture data daily from up to 10,000 participants across the globe?
.png)
